SCHEMBL22952977

SCHEMBL22952977

COc1ncc2c3c1Oc1c(ccc(O)c1O)C3CNC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 3/20 0.33
DRD5 P21918 2/20 0.33
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
HPGD P15428 3/20 0.32
RECQL P46063 3/20 0.32
TDP1 Q9NUW8 3/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 2/20 0.32
G6PD P11413 2/20 0.32
HSD17B10 Q99714 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MAPK1 P28482 2/20 0.32
NSD2 O96028 1/20 0.32
TSHR P16473 1/20 0.32
CASP7 P55210 1/20 0.32
CASP6 P55212 1/20 0.32
MEN1 O00255 1/20 0.32
FGB P02675 1/20 0.32
PRNP P04156 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952976 0.85 HTR2A (0.33) DRD1KDM4EMAPTHPGDALDH1A1
SCHEMBL22952972 0.83 DRD1 (0.34) DRD1DRD5SLC6A4HRH3DRD2
SCHEMBL22952980 0.83 SLC6A4 (0.32) SLC6A4HRH3
SCHEMBL22953389 0.79 HTR2A (0.34) DRD1DRD5HTR2APARP1
SCHEMBL22952971 0.76 HTR2A (0.35) DRD1KDM4EMAPTHPGDRECQL
SCHEMBL22953344 0.73 PARP1 (0.39) DRD1DRD5CYP3A4HSD17B10MAPK1
SCHEMBL6345215 0.72 HTR2A (0.46) DRD1DRD5KDM4EMAPTHPGD
SCHEMBL29383649 0.72 HTR2A (0.46) DRD1DRD5KDM4EMAPTHPGD
Bromide SCHEMBL3668719 0.71 HTR2A (0.45) DRD1KDM4EMAPTHPGDRECQL
SCHEMBL22952973 0.70 PARP1 (0.38) KDM4EMAPTHPGDALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed